Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130490 · ClinicalTrials.gov registry record
The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study
A clinical trial of Cataract and Healthy Eye, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 176
- Enrollment target
- 1
- Study location
NCT04130490 is a study of Cataract and Healthy Eye that has completed, run by Heidelberg Engineering. The registered enrollment target is 176 participants, below the 226-participant average among 83 other Cataract trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04130490, a study of Cataract and Healthy Eye, has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION
Conditions Studied
Interventions
- DEVICE ANTERION
Study Locations (1)
New York
- State University of New York College of Optometry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2023-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04130490
The ClinicalTrials.gov registry entry for NCT04130490 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 83 other Cataract trials with a reported enrollment target (22% lower). The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which ANTERION is the first listed.
NCT04130490 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04130490 about?
NCT04130490 is a clinical study titled "The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION
What is the current status of trial NCT04130490?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2019-10-11. Estimated completion is 2023-12-30.
What conditions does trial NCT04130490 study?
This clinical trial studies the following conditions: Cataract, Healthy Eye, Cornea Abnormality, Post-Keratorefractive Surgery, IOL.
What interventions are being tested in trial NCT04130490?
The interventions under investigation include: ANTERION (DEVICE).
Who is sponsoring clinical trial NCT04130490?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04130490 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.